These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 17118179

  • 1. Molecular surveillance of mutations in the cytochrome b gene of Plasmodium falciparum in Gabon and Ethiopia.
    Gebru T, Hailu A, Kremsner PG, Kun JF, Grobusch MP.
    Malar J; 2006 Nov 21; 5():112. PubMed ID: 17118179
    [Abstract] [Full Text] [Related]

  • 2. Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe.
    Wichmann O, Muehlberger N, Jelinek T, Alifrangis M, Peyerl-Hoffmann G, Muhlen M, Grobusch MP, Gascon J, Matteelli A, Laferl H, Bisoffi Z, Ehrhardt S, Cuadros J, Hatz C, Gjorup I, McWhinney P, Beran J, da Cunha S, Schulze M, Kollaritsch H, Kern P, Fry G, Richter J, European Network on Surveillance of Imported Infectious Diseases.
    J Infect Dis; 2004 Nov 01; 190(9):1541-6. PubMed ID: 15478057
    [Abstract] [Full Text] [Related]

  • 3. Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.
    Happi CT, Gbotosho GO, Folarin OA, Milner D, Sarr O, Sowunmi A, Kyle DE, Milhous WK, Wirth DF, Oduola AM.
    Malar J; 2006 Oct 04; 5():82. PubMed ID: 17020611
    [Abstract] [Full Text] [Related]

  • 4. Detection of atovaquone-proguanil resistance conferring mutations in Plasmodium falciparum cytochrome b gene in Luanda, Angola.
    Pimentel S, Nogueira F, Benchimol C, Quinhentos V, Bom J, Varandas L, do Rosário V, Bernardino L.
    Malar J; 2006 Apr 05; 5():30. PubMed ID: 16597338
    [Abstract] [Full Text] [Related]

  • 5. Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations.
    Musset L, Bouchaud O, Matheron S, Massias L, Le Bras J.
    Microbes Infect; 2006 Sep 05; 8(11):2599-604. PubMed ID: 16962361
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Malarone treatment failure not associated with previously described mutations in the cytochrome b gene.
    Wichmann O, Muehlen M, Gruss H, Mockenhaupt FP, Suttorp N, Jelinek T.
    Malar J; 2004 Jun 08; 3():14. PubMed ID: 15186499
    [Abstract] [Full Text] [Related]

  • 8. In vitro atovaquone/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand.
    Khositnithikul R, Tan-Ariya P, Mungthin M.
    Malar J; 2008 Jan 28; 7():23. PubMed ID: 18226262
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Different mutation patterns of atovaquone resistance to Plasmodium falciparum in vitro and in vivo: rapid detection of codon 268 polymorphisms in the cytochrome b as potential in vivo resistance marker.
    Schwöbel B, Alifrangis M, Salanti A, Jelinek T.
    Malar J; 2003 Mar 19; 2():5. PubMed ID: 12665429
    [Abstract] [Full Text] [Related]

  • 11. Late clinical failure associated with cytochrome b codon 268 mutation during treatment of falciparum malaria with atovaquone-proguanil in traveller returning from Congo.
    Massamba L, Madamet M, Benoit N, Chevalier A, Fonta I, Mondain V, Jeandel PY, Amalvict R, Delaunay P, Mosnier J, Marty P, Pomares C, Pradines B.
    Malar J; 2020 Jan 21; 19(1):37. PubMed ID: 31964401
    [Abstract] [Full Text] [Related]

  • 12. Short communication: Prevalence of mutations associated with resistance to atovaquone and to the antifolate effect of proguanil in Plasmodium falciparum isolates from northern Ghana.
    Muehlen M, Schreiber J, Ehrhardt S, Otchwemah R, Jelinek T, Bienzle U, Mockenhaupt FP.
    Trop Med Int Health; 2004 Mar 21; 9(3):361-3. PubMed ID: 14996365
    [Abstract] [Full Text] [Related]

  • 13. Direct evidence for the atovaquone action on the Plasmodium cytochrome bc1 complex.
    Siregar JE, Kurisu G, Kobayashi T, Matsuzaki M, Sakamoto K, Mi-ichi F, Watanabe Y, Hirai M, Matsuoka H, Syafruddin D, Marzuki S, Kita K.
    Parasitol Int; 2015 Jun 21; 64(3):295-300. PubMed ID: 25264100
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of Plasmodium falciparum cytochrome b gene mutations in isolates imported from Africa, and implications for atovaquone resistance.
    Berry A, Senescau A, Lelièvre J, Benoit-Vical F, Fabre R, Marchou B, Magnaval JF.
    Trans R Soc Trop Med Hyg; 2006 Oct 21; 100(10):986-8. PubMed ID: 16690094
    [Abstract] [Full Text] [Related]

  • 15. Parallel evolution of adaptive mutations in Plasmodium falciparum mitochondrial DNA during atovaquone-proguanil treatment.
    Musset L, Le Bras J, Clain J.
    Mol Biol Evol; 2007 Aug 21; 24(8):1582-5. PubMed ID: 17488741
    [Abstract] [Full Text] [Related]

  • 16. Detection of atovaquone and Malarone resistance conferring mutations in Plasmodium falciparum cytochrome b gene (cytb).
    Gil JP, Nogueira F, Strömberg-Nörklit J, Lindberg J, Carrolo M, Casimiro C, Lopes D, Arez AP, Cravo PV, Rosário VE.
    Mol Cell Probes; 2003 Aug 21; 17(2-3):85-9. PubMed ID: 12788029
    [Abstract] [Full Text] [Related]

  • 17. Molecular characterization of the cytochrome b gene and in vitro atovaquone susceptibility of Plasmodium falciparum isolates from Kenya.
    Ingasia LA, Akala HM, Imbuga MO, Opot BH, Eyase FL, Johnson JD, Bulimo WD, Kamau E.
    Antimicrob Agents Chemother; 2015 Mar 21; 59(3):1818-21. PubMed ID: 25583715
    [Abstract] [Full Text] [Related]

  • 18. Cytochrome b mutation Y268S conferring atovaquone resistance phenotype in malaria parasite results in reduced parasite bc1 catalytic turnover and protein expression.
    Fisher N, Abd Majid R, Antoine T, Al-Helal M, Warman AJ, Johnson DJ, Lawrenson AS, Ranson H, O'Neill PM, Ward SA, Biagini GA.
    J Biol Chem; 2012 Mar 23; 287(13):9731-9741. PubMed ID: 22282497
    [Abstract] [Full Text] [Related]

  • 19. Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis.
    Staines HM, Burrow R, Teo BH, Chis Ster I, Kremsner PG, Krishna S.
    J Antimicrob Chemother; 2018 Mar 01; 73(3):581-595. PubMed ID: 29237012
    [Abstract] [Full Text] [Related]

  • 20. Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa.
    Kuhn S, Gill MJ, Kain KC.
    Am J Trop Med Hyg; 2005 Apr 01; 72(4):407-9. PubMed ID: 15827276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.